BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...engineering tech in November 2019 by buying CytoCardia Inc., a company spun out of the University of Washington.As...
BioCentury | Jan 9, 2021
Tools & Techniques

What DeepMind’s leap means for structure-based drug developers

...be able to design. Last month, the spinout from University of Washington’s...
...chain Karen Tkach Tuzman Alphabet Inc. Relay Therapeutics Inc. Neoleukin Therapeutics Inc. University of Washington Atomwise...
BioCentury | Nov 24, 2020
Management Tracks

ASCO names Gralow new CMO; plus moves at Genenta, Vor, Exscientia, OncoMyx, Quanterix, Actinium, AbCellera and KBP

...2021. Gralow, a professor of medical oncology and director of breast medical oncology at the University of Washington...
BioCentury | Nov 21, 2020
Product Development

Could an approval of Biogen’s Alzheimer’s therapy still be an option?

...a professor emeritus of biostatistics at the University of Washington...
BioCentury | Nov 10, 2020
Product Development

Pfizer & Biogen: The good, the bAD and what’s next

...bullet holes." That was Scott Emerson, of University of Washington...
BioCentury | Nov 7, 2020
Regulation

Aducanumab panel criticizes FDA as it rebukes Alzheimer’s candidate

...the panel for support for those conclusions.   “This is all terrifically one-sided.” Scott Emerson, University of Washington...
...of this is terrifically one-sided,” added Emerson, who is a professor emeritus of biostatistics at the University of Washington.Panel...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...for Immunity and Immunotherapies at Seattle Children’s Research Institute and a professor of pediatrics at University of Washington...
BioCentury | Oct 6, 2020
Product Development

Industry research contributes to Nobel Prize for HCV discovery

...the 1980s. Rice and colleagues at the University of Washington...
BioCentury | Oct 6, 2020
Product Development

Warp Speed asking biopharmas to delay seeking EUA until they have enough doses

...organized by Johns Hopkins University and the University of Washington...
BioCentury | Oct 6, 2020
Regulation

White House allows FDA to release long-awaited COVID vaccine EUA guidance

...organized by Johns Hopkins University and the University of Washington.Suppressing...
Items per page:
1 - 10 of 483
BioCentury | Jan 13, 2021
Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

...engineering tech in November 2019 by buying CytoCardia Inc., a company spun out of the University of Washington.As...
BioCentury | Jan 9, 2021
Tools & Techniques

What DeepMind’s leap means for structure-based drug developers

...be able to design. Last month, the spinout from University of Washington’s...
...chain Karen Tkach Tuzman Alphabet Inc. Relay Therapeutics Inc. Neoleukin Therapeutics Inc. University of Washington Atomwise...
BioCentury | Nov 24, 2020
Management Tracks

ASCO names Gralow new CMO; plus moves at Genenta, Vor, Exscientia, OncoMyx, Quanterix, Actinium, AbCellera and KBP

...2021. Gralow, a professor of medical oncology and director of breast medical oncology at the University of Washington...
BioCentury | Nov 21, 2020
Product Development

Could an approval of Biogen’s Alzheimer’s therapy still be an option?

...a professor emeritus of biostatistics at the University of Washington...
BioCentury | Nov 10, 2020
Product Development

Pfizer & Biogen: The good, the bAD and what’s next

...bullet holes." That was Scott Emerson, of University of Washington...
BioCentury | Nov 7, 2020
Regulation

Aducanumab panel criticizes FDA as it rebukes Alzheimer’s candidate

...the panel for support for those conclusions.   “This is all terrifically one-sided.” Scott Emerson, University of Washington...
...of this is terrifically one-sided,” added Emerson, who is a professor emeritus of biostatistics at the University of Washington.Panel...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...for Immunity and Immunotherapies at Seattle Children’s Research Institute and a professor of pediatrics at University of Washington...
BioCentury | Oct 6, 2020
Product Development

Industry research contributes to Nobel Prize for HCV discovery

...the 1980s. Rice and colleagues at the University of Washington...
BioCentury | Oct 6, 2020
Product Development

Warp Speed asking biopharmas to delay seeking EUA until they have enough doses

...organized by Johns Hopkins University and the University of Washington...
BioCentury | Oct 6, 2020
Regulation

White House allows FDA to release long-awaited COVID vaccine EUA guidance

...organized by Johns Hopkins University and the University of Washington.Suppressing...
Items per page:
1 - 10 of 483